当前位置:
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
European Urology ( IF 23.4 ) Pub Date : 2024-02-18 , DOI: 10.1016/j.eururo.2023.12.019 Marco Moschini , Andrea Necchi , Francesco Montorsi
中文翻译:
回复:吉西他滨和顺铂加纳武单抗作为肌肉浸润性膀胱癌的器官保留治疗:一项 2 期试验
更新日期:2024-02-18
European Urology ( IF 23.4 ) Pub Date : 2024-02-18 , DOI: 10.1016/j.eururo.2023.12.019 Marco Moschini , Andrea Necchi , Francesco Montorsi
中文翻译:
回复:吉西他滨和顺铂加纳武单抗作为肌肉浸润性膀胱癌的器官保留治疗:一项 2 期试验